Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients

NCT03264690 is registered in ClinicalTrials.gov with Eisai Korea Inc. as lead sponsor.

NCT NCT03264690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03264690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients
Lead sponsor
Eisai Korea Inc.
Phase
Observational
Overall status
Completed
Start date
September 21, 2017
Completion date
January 16, 2020
Enrollment
40 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel disease